Literature DB >> 18641202

Nongallated compared with gallated flavan-3-ols in green and black tea are more bioavailable.

Susanne M Henning1, Jung J Choo, David Heber.   

Abstract

Green tea and black tea (BT) contain gallated [(-)-epigallocatechin-3-gallate (EGCG), (-)-epicatechin-3-gallate] and nongallated [(-)-epicatechin, (-)-epigallocatechin (EGC)] tea polyphenols (PP). During BT production, PP undergo oxidation and form larger polymers such as theaflavins (THE) and thearubigins, which contribute to the health benefit of BT. This article gives an overview of the role of chemical characteristics and endogenous metabolism of tea PP and their bioavailability in humans and describes attempts to increase their bioavailability. At pH close to neutral, EGCG and EGC form homo- and heterodimers generating hydrogen peroxide. To confirm the pH instability of EGCG, EGC, and THE in cell culture medium, their antiproliferative activity was determined in the presence and absence of catalase. The antiproliferative activity in LNCaP prostate cancer cells was decreased when incubated with catalase prior to EGCG, EGC, and THE treatment. In addition, new findings demonstrated that the formation of methyl-EGC increased the stability at neutral pH compared with EGC. Approaches to increase the bioavailability of flavan-3-ols are reviewed, which include the administration of tea in combination with fruit juices, coadministration with piperine, and peracetylation of EGCG. Future intervention studies will need to focus on the bioactivity not only of green tea and BT PP but also of their metabolites and biotransformation products.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18641202      PMCID: PMC2942025          DOI: 10.1093/jn/138.8.1529S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  38 in total

1.  Of the major phenolic acids formed during human microbial fermentation of tea, citrus, and soy flavonoid supplements, only 3,4-dihydroxyphenylacetic acid has antiproliferative activity.

Authors:  Kun Gao; Anlong Xu; Cyrille Krul; Koen Venema; Yong Liu; Yantao Niu; Jinxiu Lu; Liath Bensoussan; Navindra P Seeram; David Heber; Susanne M Henning
Journal:  J Nutr       Date:  2006-01       Impact factor: 4.798

2.  Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers.

Authors:  C S Yang; L Chen; M J Lee; D Balentine; M C Kuo; S P Schantz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1998-04       Impact factor: 4.254

3.  Human fecal water content of phenolics: the extent of colonic exposure to aromatic compounds.

Authors:  Andrew M Jenner; Joseph Rafter; Barry Halliwell
Journal:  Free Radic Biol Med       Date:  2005-03-15       Impact factor: 7.376

4.  Tea polyphenols and theaflavins are present in prostate tissue of humans and mice after green and black tea consumption.

Authors:  Susanne M Henning; William Aronson; Yantao Niu; Francisco Conde; Nicolas H Lee; Navindra P Seeram; Ru-Po Lee; Jinxiu Lu; Diane M Harris; Aune Moro; Jenny Hong; Leung Pak-Shan; R James Barnard; Hossein G Ziaee; George Csathy; Vay L W Go; Hejing Wang; David Heber
Journal:  J Nutr       Date:  2006-07       Impact factor: 4.798

5.  Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals.

Authors:  H-H Sherry Chow; Iman A Hakim; Donna R Vining; James A Crowell; James Ranger-Moore; Wade M Chew; Catherine A Celaya; Steven R Rodney; Yukihiko Hara; David S Alberts
Journal:  Clin Cancer Res       Date:  2005-06-15       Impact factor: 12.531

6.  Peracetylation as a means of enhancing in vitro bioactivity and bioavailability of epigallocatechin-3-gallate.

Authors:  Joshua D Lambert; Shengmin Sang; Jungil Hong; Seok-Joo Kwon; Mao-Jung Lee; Chi-Tang Ho; Chung S Yang
Journal:  Drug Metab Dispos       Date:  2006-09-22       Impact factor: 3.922

7.  Analysis of (+)-catechin, (-)-epicatechin and their 3'- and 4'-O-methylated analogs. A comparison of sensitive methods.

Authors:  J L Donovan; D L Luthria; P Stremple; A L Waterhouse
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1999-04-16

Review 8.  Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets.

Authors:  Charles Ramassamy
Journal:  Eur J Pharmacol       Date:  2006-06-17       Impact factor: 4.432

Review 9.  Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies.

Authors:  Peeter Karihtala; Ylermi Soini
Journal:  APMIS       Date:  2007-02       Impact factor: 3.205

10.  Consumption of both black tea and green tea results in an increase in the excretion of hippuric acid into urine.

Authors:  Theo P Mulder; Anton G Rietveld; Johan M van Amelsvoort
Journal:  Am J Clin Nutr       Date:  2005-01       Impact factor: 7.045

View more
  32 in total

1.  Epigenetic mechanisms underlying diet-sourced compounds in the prevention and treatment of gastrointestinal cancer.

Authors:  Rebecca W Knackstedt; Vondina R Moseley; Michael J Wargovich
Journal:  Anticancer Agents Med Chem       Date:  2012-12       Impact factor: 2.505

2.  Quercetin increased bioavailability and decreased methylation of green tea polyphenols in vitro and in vivo.

Authors:  Piwen Wang; David Heber; Susanne M Henning
Journal:  Food Funct       Date:  2012-06       Impact factor: 5.396

3.  A preliminary investigation of the impact of catechol-O-methyltransferase genotype on the absorption and metabolism of green tea catechins.

Authors:  Rosalind J Miller; Kim G Jackson; Tony Dadd; Beate Nicol; Joanne L Dick; Andrew E Mayes; A Louise Brown; Anne M Minihane
Journal:  Eur J Nutr       Date:  2011-03-29       Impact factor: 5.614

4.  Prospective randomized trial evaluating blood and prostate tissue concentrations of green tea polyphenols and quercetin in men with prostate cancer.

Authors:  Susanne M Henning; Piwen Wang; Ru-Po Lee; Amy Trang; George Husari; Jieping Yang; Emma M Grojean; Austin Ly; Mark Hsu; David Heber; Tristan Grogan; Zhaoping Li; William J Aronson
Journal:  Food Funct       Date:  2020-04-29       Impact factor: 5.396

Review 5.  Epigenetic effects of green tea polyphenols in cancer.

Authors:  Susanne M Henning; Piwen Wang; Catherine L Carpenter; David Heber
Journal:  Epigenomics       Date:  2013-12       Impact factor: 4.778

6.  Nanolipidic particles improve the bioavailability and alpha-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease.

Authors:  Adam Smith; Brian Giunta; Paula C Bickford; Michael Fountain; Jun Tan; R Douglas Shytle
Journal:  Int J Pharm       Date:  2010-01-18       Impact factor: 5.875

7.  N- and S-homocysteinylation reduce the binding of human serum albumin to catechins.

Authors:  Angelo Zinellu; Salvatore Sotgia; Bastianina Scanu; Dionigia Arru; Annalisa Cossu; Anna Maria Posadino; Roberta Giordo; Arduino A Mangoni; Gianfranco Pintus; Ciriaco Carru
Journal:  Eur J Nutr       Date:  2015-12-10       Impact factor: 5.614

Review 8.  Tea and health: studies in humans.

Authors:  Naghma Khan; Hasan Mukhtar
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

9.  Lack of evidence for green tea polyphenols as DNA methylation inhibitors in murine prostate.

Authors:  Shannon R Morey Kinney; Wa Zhang; Marien Pascual; John M Greally; Bryan M Gillard; Ellen Karasik; Barbara A Foster; Adam R Karpf
Journal:  Cancer Prev Res (Phila)       Date:  2009-11-24

10.  Phenolic acid concentrations in plasma and urine from men consuming green or black tea and potential chemopreventive properties for colon cancer.

Authors:  Susanne M Henning; Piwen Wang; Narine Abgaryan; Roberto Vicinanza; Daniela Moura de Oliveira; Yanjun Zhang; Ru-Po Lee; Catherine L Carpenter; William J Aronson; David Heber
Journal:  Mol Nutr Food Res       Date:  2013-01-14       Impact factor: 5.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.